PlumX Metrics
Embed PlumX Metrics

The Use of a New Dedicated Electrocautery Lumen-Apposing Metal Stent for Gallbladder Drainage in Patients with Acute Cholecystitis

Diagnostics, ISSN: 2075-4418, Vol: 13, Issue: 21
2023
  • 4
    Citations
  • 0
    Usage
  • 9
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent Blog

Diagnostics, Vol. 13, Pages 3341: The Use of a New Dedicated Electrocautery Lumen-Apposing Metal Stent for Gallbladder Drainage in Patients with Acute Cholecystitis

Diagnostics, Vol. 13, Pages 3341: The Use of a New Dedicated Electrocautery Lumen-Apposing Metal Stent for Gallbladder Drainage in Patients with Acute Cholecystitis Diagnostics doi:

Most Recent News

Research from IRCCS Humanitas Research Hospital Provides New Data on Acute Cholecystitis (The Use of a New Dedicated Electrocautery Lumen-Apposing Metal Stent for Gallbladder Drainage in Patients with Acute Cholecystitis)

2023 NOV 15 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Daily News -- New study results on acute cholecystitis have been published.

Article Description

Aims: Lumen-apposing metal stents (LAMSs) in ultrasonography-guided gallbladder drainage (EUS-GBD) have become increasingly important for high-risk surgical patients. Our study aims to evaluate the technical and clinical success, safety, and feasibility of endoscopic ultrasonography-guided gallbladder drainage using a new dedicated LAMS. Methods: This is a retrospective multicenter study that included all consecutive patients not suitable for surgery who were referred to a tertiary center for EUS-GBD using a new dedicated electrocautery LAMS for acute cholecystitis at eight different centers. Results: Our study included 54 patients with a mean age of 76.48 years (standard deviation: 12.6 years). Out of the 54 endoscopic gallbladder drainages performed, 24 (44.4%) were cholecysto-gastrostomy, and 30 (55.4%) were cholecysto-duodenostomy. The technical success of LAMS placement was 100%, and clinical success was achieved in 23 out of 30 patients (76.67%). Adverse events were observed in two patients (5.6%). Patients were discharged after a median of 5 days post-stenting. Conclusions: EUS-GBD represents a valuable option for high-surgical-risk patients with acute cholecystitis. This new dedicated LAMS has demonstrated a high rate of technical and clinical success, along with a high level of safety.

Bibliographic Details

Brandaleone, Luca; Franchellucci, Gianluca; Facciorusso, Antonio; Samanta, Jayanta; Moon, Jong Ho; Vargas-Madrigal, Jorge; Robles Medranda, Carlos; Barbera, Carmelo; Di Matteo, Francesco; Bulajic, Milutin; Auriemma, Francesco; Paduano, Danilo; Calabrese, Federica; Gentile, Carmine; Massidda, Marco; Bianchi, Marco; De Luca, Luca; Polverini, Davide; Masoni, Benedetta; Poletti, Valeria; Marcozzi, Giacomo; Hassan, Cesare; Repici, Alessandro; Mangiavillano, Benedetto

MDPI AG

Biochemistry, Genetics and Molecular Biology

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know